We are live on ! Find out more
SXTPW icon

60 Degrees Pharmaceuticals Warrant

7 hedge funds and large institutions have $19.1K invested in 60 Degrees Pharmaceuticals Warrant in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

27.66% more ownership

Funds ownership: 6.29%33.96% (+28%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

13% less funds holding

Funds holding: 87 (-1)

57% less capital invested

Capital invested by funds: $43.9K → $19.1K (-$24.9K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Capital
1
Walleye Capital
New York
$6.62K
SM
2
Sabby Management
Florida
$4.81K -$3.16K -109,198 -40%
CS
3
Clear Street
New York
$4.35K -$4 -132 -0.1%
Citadel Advisors
4
Citadel Advisors
Florida
$1.71K +$41 +1,402 +3%
TC
5
Torno Capital
Massachusetts
$1.4K
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Quebec, Canada
$150
UBS Group
7
UBS Group
Switzerland
$15 +$12 +426 +533%
WAM
8
Warberg Asset Management
Illinois
-$1.51K -29,515 Closed

SXTPW Hedge Fund Activity: Q4 2024 in Review

7 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q4 2024, worth a combined $19.1K — down 57% from $43.9K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SXTPW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, adding an estimated $41. The largest seller was Sabby Management, cutting an estimated $3.16K.

  • 7 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q4 2024, down from 8 in Q3 2024.
  • Funds reported $19.1K of 60 Degrees Pharmaceuticals Warrant stock for Q4 2024, down 57% quarter-over-quarter.
  • 0 funds opened new 60 Degrees Pharmaceuticals Warrant positions in Q4 2024 and 1 closed out, a net change of -1 holder.
  • The largest 60 Degrees Pharmaceuticals Warrant buyer in Q4 2024 was Citadel Advisors, an estimated $41 added.
  • The largest 60 Degrees Pharmaceuticals Warrant seller in Q4 2024 was Sabby Management, an estimated $3.16K sold.

Based on aggregated 13F filings for Q4 2024.